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OBJECTIVES We characterized pharmacologically the slow conduction zone of verapamil-sensitive idio-
pathic left ventricular tachycardia (ILVT) with regard to the late diastolic potential (LDP).
BACKGROUND We showed that the slow conduction zone of ILVT could be divided into two components
by LDP; that is, the distal component with a tachycardia-dependent conduction delay
property and the proximal one without it.
METHODS Electrophysiologic studies were performed in eight consecutive patients. The LDP was
recorded during left ventricular (LV) mapping during ILVT. Entrainment was performed
from the right ventricular outflow tract while recording LDP. The effects of lidocaine
(1 mg/kg body weight) and verapamil (0.5 or 1.0 mg) were examined during entrainment.
RESULTS The LDPs preceding the Purkinje potential (PP) were serially recorded from the upper third
to the middle of the LV septum along the narrow longitudinal line. The ventricular
tachycardia (VT) cycle length increased after lidocaine (p , 0.05), and further after verapamil
(p , 0.05). The increments in the VT cycle length after administration of the drugs strongly
correlated with those in LDP-PP (r . 0.9 for both drugs). The interval from the ventricular
potential to LDP was unchanged after administration of the drugs. In one patient, verapamil
terminated VT by local conduction block between LDP and PP. The LDP-PP measured
during entrainment increased after lidocaine, and further after verapamil, whereas the interval
from the stimulus to LDP remained unchanged.
CONCLUSIONS The component distal to LDP is mainly calcium channel-dependent and partly depressed
sodium channel-dependent. The proximal component is considered to be sodium channel-
dependent (normal). (J Am Coll Cardiol 2001;37:1415–21) © 2001 by the American
College of Cardiology
Verapamil-sensitive idiopathic left ventricular tachycardia
(ILVT) constitutes a relatively small but distinct entity
occurring in relatively young patients (1–9). It has been
shown in most patients that the underlying mechanism of
ILVT is re-entry with an excitable gap (3–7). With the use
of the entrainment technique (10–12), we showed that a
slow conduction zone with a conduction delay property in
response to the increase in the pacing rate is present
between the right ventricular outflow tract (RVOT) and the
earliest ventricular activation site at the posteroapical left
ventricular (LV) septum. In addition, we found that small
doses of verapamil and lidocaine selectively suppress con-
duction through this slow conduction zone of ILVT (4,5,7).
Recently, we reported that a discrete late diastolic poten-
tial (LDP) preceding the Purkinje potential (PP) was
recorded in the middle to upper third LV septum during
ILVT, and the entire slow conduction zone could be divided
into two components by LDP: one in the distal part to the
LDP recording site, showing a conduction delay property
(the distal component), and the other in the proximal part
to the LDP recording site, showing no conduction delay
property (the proximal component) (7). In the present
study, we examined the responses of these two components
to lidocaine (a sodium channel-blocking agent) and vera-
pamil (a calcium channel-blocking agent) both during
ventricular tachycardia (VT) and entrainment.
METHODS
Study patients. Eight consecutive patients (6 men and 2
women, 16 to 44 years old) with recurrent, sustained VT
and with no underlying heart disease were studied. The
electrocardiogram (ECG) recorded during VT exhibited a
right bundle branch block configuration and a superior or
left axis in all patients. Intravenous verapamil (5 to 10 mg) was
demonstrated to be effective in terminating VT in all patients.
Electrophysiologic study. Written, informed consent was
obtained from all patients before the study. All antiarrhyth-
mic drugs were discontinued for .5 half-lives of each drug
before the study. Using standard techniques, two or three
6F quadripolar electrode catheters (Josephson, Bard Elec-
trophysiology, Billerica, Massachusetts) were placed at the
right ventricular (RV) apex, RVOT and/or His bundle
region and were used for recording bipolar electrograms and
pacing. A 7F deflectable quadripolar electrode catheter with
a 2-mm interelectrode interval (Radii-T, Cardiac Pathways,
Sunnyvale, California) (n 5 8) or a 6F deflectable eight-
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pole electrode catheter with a 2.5-mm interelectrode inter-
val (EPT-Dx-S, EP Technology, Sunnyvale, California)
(n 5 4) was retrogradely inserted into the LV to perform
endocardial mapping during VT to identify the earliest
ventricular activation site and to record LDP by recording
electrograms from the each electrode pair. All bipolar
electrograms were filtered between a bandpass of 50 and
600 Hz and recorded simultaneously with three or six ECG
leads (I, II, III, aVF, V1 and V5) with the use of a polygraph
(Cardiolab system, Prucka Engineering, Houston, Texas).
Ventricular pacing was performed at a stimulus strength of
twice the diastolic threshold and with a pulse width of 2 ms,
using a programmable stimulator (SEC-3102, Nihon Ko-
hden, Tokyo, Japan).
Entrainment from RVOT. Only the quadripolar catheter
was used to record LDP in the entrainment study, because
we could not stabilize the position of the eight-pole elec-
trode catheter in the LV, and thus we could not record
stable LDP during the entrainment study. We positioned
the tip of the quadripolar catheter at the earliest LDP
recording site and used this LDP in measuring local
conduction times during entrainment as well as during VT.
In all patients, entrainment of VT by pacing from the
RVOT at a rate 5 to 10 beats/min faster than the induced
VT rate was attempted while recording the LDP. When
VT was still present after termination of the pacing, rapid
pacing was again performed, with an increase in the pacing
rate by 5 to 10 beats/min. This procedure was repeated until
VT was interrupted or pacing reached the rate of 40 to 50
beats/min faster than the VT rate. In the last entrained beat,
the intervals from the stimulus artifact to the electrogram at
the RV apex (st-RVA) and from the stimulus artifact to the
LDP (st-LDP), as well as that from the LDP to PP
(LDP-PP), were measured at every pacing rate.
Effects of lidocaine and verapamil during entrainment.
During VT, lidocaine (1 mg/kg body weight over 1 min)
was intravenously administered in six of eight patients, and
the entrainment study was repeated. Approximately 15 min
after the lidocaine study, when the VT rate and local
conduction times returned to the control values, a small dose
of verapamil (0.5 mg) was intravenously administered to all
patients. When the VT rate was not decreased by about 20
beats/min, another dose of 0.5 mg (total dose 1.0 mg) was
administered. The entrainment study was repeated in seven
of eight patients. In the remaining one patient, verapamil
(1.0 mg) resulted in VT termination, and the entrainment
study was not performed. Throughout the study, we held
the catheter carefully to avoid applying pressure at the tip of
the catheter.
Before and after injection of each antiarrhythmic agent,
the VT cycle length and the intervals from PP to the local
ventricular potential (VP) (PP-VP), from VP to LDP
(VP-LDP) and from LDP to PP (LDP-PP) were measured
during VT. Measurements of st-LDP, st-RVA and
LDP-PP during entrainment were repeated at every pacing
rate after each antiarrhythmic agent.
Data analysis. Continuous variables were expressed as the
mean value 6 SD. Statistical analysis was done with
repeated measures one-way analysis of variance, in which
the F value was interpreted on the basis of Huyhn-Feld
corrected p values. Subsequent multiple comparisons were
performed by using a Bonferroni-type multiple comparison
test for three or more variables. Correlations were tested by
the Pearson correlation coefficient. For the analysis of the
effect of verapamil on the relationship between LDP-PP
and pacing rate, we performed a multiple regression analysis
using a dummy variable to encode the treatment condition
within each patient, as well as dummy variables to encode
the eight different patients. A p value ,0.05 was considered
statistically significant.
RESULTS
Sustained VT with a mean cycle length of 342.8 6 49.3 ms
(rate 178.3 6 26.1 beats/min) and with the same QRS
morphology as that of spontaneous VT was repeatedly
induced in all patients. Endocardial mapping during VT
identified the earliest ventricular activation site at the
posteroapical LV septum, with an activation time of
225.5 6 3.1 ms, relative to the onset of the QRS complex
in all patients. The LDPs preceding PP were recorded
serially from the upper third to the middle of the LV septum
along the narrow longitudinal line in four patients in whom
ventricular mapping with the eight-pole catheter was per-
formed (Fig. 1). The LDP appeared earlier as the recording
site became closer to the base of the LV. At the middle or
lower third of the LV septum, the LDP appeared latest and
was fused with PP. We used the earliest LDP in measuring
the local conduction times. The LDP-PP, PP-VP and
VP-LDP intervals at the earliest LDP recording site were
68.5 6 24.3 ms, 21.4 6 7.2 ms and 256.3 6 39.1 ms,
respectively, and the duration of the LDP was 21.5 6
3.4 ms.
Effects of lidocaine and verapamil on local conduction
times and VT cycle length. In all patients but one, neither
lidocaine nor verapamil terminated VT. After lidocaine
(1 mg/kg per min), the VT cycle length significantly
increased from 355.3 6 50.6 to 377.5 6 45.3 ms (p , 0.01
vs. control). The LDP-PP increased from 77.7 6 18.9 to
Abbreviations and Acronyms
ILVT 5 idiopathic left ventricular tachycardia
LDP 5 late diastolic potential
LV 5 left ventricular
PP 5 Purkinje potential
RV 5 right ventricular
RVA 5 right ventricular apex
RVOT 5 right ventricular outflow tract
st 5 stimulus
VP 5 ventricular potential
VT 5 ventricular tachycardia
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99.2 6 17.0 ms (p , 0.05 vs. control), whereas PP-VP and
VP-LDP remained unchanged. After verapamil (0.5 or
1.0 mg), the VT cycle length increased from 347.0 6 52.4
to 394.6 6 60.1 ms (p , 0.01 before verapamil), which was
significantly greater than that after lidocaine (p , 0.05), and
LDP-PP also increased from 76.3 6 28.2 to 118.9 6
34.1 ms (p , 0.01 before verapamil), which was signifi-
cantly greater than that after lidocaine (p , 0.05), whereas
PP-VP and VP-LDP remained unchanged. The LDP
duration did not significantly change after lidocaine and
verapamil. The increases in the VT cycle length after
lidocaine and verapamil significantly correlated with those
in LDP-PP (r 5 0.98, p 5 0.0006 for control vs. lidocaine;
r 5 0.93, p 5 0.0009 for pre-verapamil vs. post-verapamil)
(Fig. 2). Neither of them was correlated with the change in
PP-VP (r 5 0.18, p 5 0.74 for control vs. after lidocaine;
r 5 0.10, p 5 0.81 for pre-verapamil vs. post-verapamil) or
the change in VP-LDP (r 5 0.17, p 5 0.75 for control vs.
after lidocaine; r 5 0.53, p 5 0.18 for pre-verapamil vs.
post-verapamil).
In one patient, verapamil induced a beat-to-beat variation
in both the VT cycle length and LDP-PP and terminated
VT, with local conduction block between the LDP and PP
recording sites (Fig. 3). Both PP-VP and VP-LDP were
Figure 1. Examples of late diastolic potentials (LDPs) (arrows) preceding Purkinje potential (PP) in four patients (cases 1, 4, 5 and 6), recorded serially
from the middle to upper third of the left ventricular (LV) septum along the narrow longitudinal line during ventricular tachycardia (VT). Tracings are
electrocardiographic leads I, II and V1, and intracardiac electrograms are recorded from the His bundle region (His), right ventricular apex (RVA), right
ventricular outflow tract (RVOT) and eight-electrode catheter located in the LV septum (LV1 to LV8). All numbers are in ms. A 5 atrial potential; H 5
His bundle potential.
Figure 2. Correlations of the increases in VT cycle length (DCL) with
those of the intervals from LDP to PP (DLDP-PP) after lidocaine
(1 mg/kg) and verapamil (0.5 or 1.0 mg). There were significant correla-
tions between the increases in VT cycle length and those in LDP-PP after
lidocaine and verapamil (r 5 0.98, p 5 0.0006 for control study vs.
post-lidocaine; r 5 0.93, p 5 0.0009 for pre-verapamil vs. post-verapamil).
Abbreviations as in Figure 1.
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almost constant after verapamil administration. The VT
cycle length was significantly correlated with LDP-PP (r 5
0.99, p 5 0.0001), although not with PP-VP (r 5 0.19, p 5
0.65) or VP-LDP (r 5 0.08, p 5 0.85).
Ventricular tachycardia entrainment and the effects of
lidocaine and verapamil. In all patients, entrainment phe-
nomena, including constant fusion, except for the last
entrained beat, and progressive fusion, were demonstrated
by rapid pacing from the RVOT. A long conduction
interval between the pacing site and the earliest ventricular
activation site, indicating a slow conduction zone, was
demonstrated during entrainment.
We also performed VT entrainment while recording the
earliest LDP and examined the effects of lidocaine and vera-
pamil. The LDP was captured orthodromically during entrain-
ment, whereas the ventricular potentials at the LDP recording
site and RVA were captured antidromically. The st-LDP and
LDP-PP, which were measured in the last entrained beat, were
319.1 6 34.8 ms and 81.9 6 34.8 ms, respectively, at the
pacing cycle length of 320.7 6 49.6 ms. The st-RVA was
58.8 6 14.1 ms. It is noted that st-LDP was much longer than
LDP-PP, and the percentages of st-LDP and LDP-PP to the
interval from the stimulus artifact to PP, which was measured
in the slowest pacing rate, were 80 6 5% and 20 6 5%,
respectively (Table 1). When the pacing rate was increased,
LDP-PP was prolonged, whereas st-LDP and st-RVA re-
mained unchanged in all patients.
Figure 4 shows an example of the effects of lidocaine and
verapamil on st-LDP, LDP-PP and st-RVA measured
during entrainment. During the control study, st-LDP,
LDP-PP and st-RVA were 370, 112 and 40 ms, respec-
tively. After lidocaine administration, LDP was again cap-
tured orthodromically, and LDP-PP was prolonged to
168 ms, whereas st-LDP and st-RVA remained unchanged.
After verapamil administration, LDP was captured ortho-
dromically, and LDP-PP was further prolonged to 212 ms,
whereas st-LDP and st-RVA remained unchanged. The
effects of lidocaine (n 5 6) and verapamil (n 5 7) on local
conduction times measured during entrainment are shown
in Table 1. In all patients, LDP-PP measured during
entrainment was prolonged after lidocaine and was further
prolonged after verapamil, although the pacing rate used for
entrainment was lower, especially after verapamil, as com-
pared with that during the control study. The st-LDP and
st-RVA remained unchanged. The relationship between the
LDP-PP interval and pacing rate was compared between
the conditions during the control study and those after
verapamil administration, by using multiple linear regres-
sion. The regression equation was expressed as follows:
when LDP-PP was named “Y” and the pacing rate “X,” Y 5
2255.56 1 44.25S1 1 32.38S2 1 129.74S3 2 88.28S4 2
43.53S5 1 74.40S6 2 95.92S7 1 2.04X 1 12.91D 2
0.294X 3 D. In this equation, D is a dummy variable to
encode before verapamil (D 5 1) and after verapamil (D 5
Figure 3. A beat-to-beat variation in the VT cycle length occurred after intravenous administration of verapamil (1 mg). Tracings are ECG leads I, II, III,
aVF and V1, and intracardiac electrograms are recorded at the RVOT and RVA, with the distal and proximal pairs of the mapping catheter where LDP
was recorded (proximal and distal LDP sites), as well as ECG lead V5. Note that the VT cycle length and the interval from LDP to PP were variable,
whereas the intervals from PP to the local ventricular potential (VP) and from VP to LDP were almost constant. It is also noted that VT was finally
terminated due to local conduction block between the LDP and PP recording sites. All numbers are in ms. Abbreviations as in Figure 1.
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21); S1 through S7 are subject dummy variables; the
number 12.91 in the term 12.91D is a intercept shift caused
by verapamil; and 20.294 in the term 20.294X represents
a verapamil-induced change in the slope in which p 5
0.0078. From these findings, the increase in LDP-PP in
response to the increase in the pacing rate was augmented
after verapamil administration.
DISCUSSION
In this study, LDP preceding PP was recorded serially from
the upper third to the middle of the LV septum along the
narrow longitudinal line during VT. The earliest LDP was
recorded at the base of the LV septum, whereas the latest LDP
recorded at the middle or lower third of the LV septum was
fused with PP. We measured the local conduction times with
the use of the earliest LDP and found that the interval from
the LDP to PP increased during entrainment in response to an
increase in the pacing rate, whereas the st-LDP interval was
constant. Thus, it is suggested that the earliest LDP reflects the
excitation at the entrance of a “specific” component of slow
conduction, and the following serially recorded LDPs might
represent the serial excitations in this component.
Effects of lidocaine and verapamil on VT cycle length. A
small dose of verapamil and lidocaine selectively suppressed the
Figure 4. Examples of entrainment by pacing from the RVOT at a rate of 145 beats/min while recording LDP during the control study (upper panel),
after lidocaine administration (middle panel) and after verapamil administration (lower panel). Tracings are ECG leads I, II and V1, and intracardiac
electrograms are recorded at the His bundle region (His), RVOT, RVA and LDP site (arrows). All numbers are in ms. The numbers in circles indicate conduction
intervals from the LDP stimulus artifact (st) to the electrogram at the RVA and from LDP to PP. See text for discussion. Abbreviations as in Figure 1.
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conduction through the distal component, but neither of them
affected the conduction in the proximal component, because
LDP-PP was prolonged by the drugs, although PP-LDP was
not. The increments in the VT cycle length after administering
these drugs correlated with those in LDP-PP. Furthermore, in
one patient, verapamil induced a beat-to-beat variation of the
VT cycle length and LDP-PP interval and terminated VT,
with local conduction block within the distal component. We
held the catheter carefully throughout the study to avoid
applying pressure at the tip of catheter, because pressure could
cause the same phenomenon (7). Thus, verapamil and lido-
caine slowed the VT rate by selectively suppressing the con-
duction through the distal component.
Ventricular tachycardia entrainment and the effects of
lidocaine and verapamil. To further elucidate this issue,
we performed entrainment while recording LDP before and
after lidocaine and verapamil administration. We found that
verapamil selectively suppressed the conduction through the
distal component, because LDP-PP, but not st-LDP, was
prolonged after verapamil. The magnitude of the increase in
LDP-PP with an increase in the pacing rate was augmented
after verapamil. Thus, it is further confirmed that the target
site of verapamil is confined to the distal component. This
study also showed that lidocaine slightly but significantly
suppressed the conduction through the distal component.
The present dose of lidocaine is unlikely to affect conduction
within the normal myocardium, unless the pacing rate is
sufficiently high, but it might suppress conduction through
the myocardial cells with partially depolarized membrane
potential (13,14). These findings suggested that the main
cellular mechanism of the conduction through the distal
component is calcium channel-dependent and also involves
depressed sodium channel-dependent tissue.
In contrast, the conduction through the proximal com-
ponent was affected by neither lidocaine nor verapamil,
suggesting that the cellular mechanism of the proximal
component is sodium channel-dependent (normal). The
conduction time through the proximal component was
relatively long and occupied 80 6 5% of the total conduc-
tion time from the stimulus artifact to PP during entrain-
ment. Anatomically, it reflects conduction from the RVOT
to the upper LV septum, and the distance was ;3 to 4 cm
at most, if measured directly. In general, conduction velocity
through tissue with normal sodium channel-dependent
conduction is expected to be faster than that through tissue
operated by the other cellular mechanism (13). Thus, the
conduction velocity in this proximal component is too slow
to be explained by the conduction through the normal
ventricular tissue with normal sodium channel-dependent
conduction. It was reported that the conduction velocity of
a fiber is reduced as the diameter is decreased and the length
is increased (15). Thus, we submit a hypothesis that the
excitation in the proximal component is conducted along an
anatomically isolated, long, thin pathway, such as the
transverse LV false tendon. This structure, which extends
from the posteroinferior LV to the LV septum, in many
cases, was reported to be related to ILVT (16,17). Further
studies are required to clarify this issue.
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